1-3 of 3
Suzanne Cheng
Close
Sort by
Journal Articles

Results of the Phase 1 Trial of RG7112, a Small-Molecule MDM2 Antagonist, in Acute Leukemia

Michael Andreeff, MD, PhD, Kevin R. Kelly, MD, Karen Yee, MD, Sarit Assouline, Roger Strair, MD, PhD, Leslie Popplewell, MD, David Bowen, Giovanni Martinelli, MD, Mark W. Drummond, PhD, FRCPath, MB, CHB, Paresh Vyas, MD, Mark Kirschbaum, MD, Swaminathan Padmanabhan Iyer, MD, Kensuke Kojima, MD, PhD, David Geho, MD, Steven Blotner, PhD, Suzanne Cheng, PhD, Lyubomir Vassilev, PhD, Meichun Ding, PhD, Jianguo Zhi, PhD, Steven Middleton, PhD, Gwen Nichols, MD
Journal: Blood
Blood (2012) 120 (21): 675.
https://doi.org/10.1182/blood.V120.21.675.675
Published: 2012
Journal Articles

The TNF-a Gene Modifies Stroke Risk in Children with Sickle Cell Anemia: Results from the STOP Trial.

Carolyn Hoppe, MD, William Klitz, PhD, Katherine D’Harlingue, BS, Suzanne Cheng, PhD, Lori Steiner, MS, Robert Adams, MD, Lori Styles, MD
Journal: Blood
Blood (2005) 106 (11): 77.
https://doi.org/10.1182/blood.V106.11.77.77
Published: 2005
Journal Articles

Gene interactions and stroke risk in children with sickle cell anemia

Clinical Trials & Observations
Carolyn Hoppe, William Klitz, Suzanne Cheng, Ray Apple, Lori Steiner, Lara Robles, Tom Girard, Elliott Vichinsky, Lori Styles, the CSSCD Investigators
Journal: Blood
Blood (2004) 103 (6): 2391–2396.
https://doi.org/10.1182/blood-2003-09-3015
Published: 2004